Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Revenue (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Revenue for 17 consecutive years, with $226.2 million as the latest value for Q1 2026.

  • Quarterly Revenue rose 5.89% to $226.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $925.3 million through Jan 2026, up 8.28% year-over-year, with the annual reading at $925.3 million for FY2026, 8.28% up from the prior year.
  • Revenue for Q1 2026 was $226.2 million at Usana Health Sciences, up from $213.7 million in the prior quarter.
  • The five-year high for Revenue was $362.3 million in Q1 2022, with the low at $200.2 million in Q3 2024.
  • Average Revenue over 5 years is $238.9 million, with a median of $228.0 million recorded in 2022.
  • The sharpest move saw Revenue tumbled 37.09% in 2022, then grew 10.79% in 2025.
  • Over 5 years, Revenue stood at $228.0 million in 2022, then fell by 3.02% to $221.1 million in 2023, then dropped by 3.38% to $213.6 million in 2024, then rose by 0.03% to $213.7 million in 2025, then grew by 5.86% to $226.2 million in 2026.
  • According to Business Quant data, Revenue over the past three periods came in at $226.2 million, $213.7 million, and $235.8 million for Q1 2026, Q3 2025, and Q2 2025 respectively.